cytarabine has been researched along with Pulmonary Veno Occlusive Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, M; Ezoe, A; Hirayama, Y; Kohda, K; Kuga, T; Matsumoto, S; Mochizuki, C; Nakazawa, O; Nobuoka, A | 1 |
1 other study(ies) available for cytarabine and Pulmonary Veno Occlusive Disease
| Article | Year |
|---|---|
Pulmonary veno-occlusive disease accompanied by microangiopathic hemolytic anemia 1 year after a second bone marrow transplantation for acute lymphoblastic leukemia.
Topics: Adolescent; Adrenal Cortex Hormones; Anemia, Hemolytic; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Transplantation; Cytarabine; Fatal Outcome; Female; Graft vs Host Disease; Hemolytic-Uremic Syndrome; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Diseases, Fungal; Mitoxantrone; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Veno-Occlusive Disease; Retreatment; Transplantation Conditioning | 1996 |